25 May 2013
Keywords: lotemax, phiii, studies, completed, pharmos, its, phase
Article | 25 March 1996
- Pharmos has completed its Phase III studies of Lotemax (loteprednol
etabonate), its site-specific steroid for seasonal allergic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 June 1996
24 May 2013
© 2013 thepharmaletter.com